Onconetix, Inc. Amortization of Debt Issuance Costs and Discounts
Onconetix, Inc. (ONCO) reported Amortization of Debt Issuance Costs and Discounts of $291.96 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2024-08-29
- Onconetix, Inc. amortization of debt issuance costs and discounts for the quarter ending 2024-06-30 was $109.03K.
- Onconetix, Inc. amortization of debt issuance costs and discounts for the quarter ending 2024-03-31 was $182.93K.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month |
|---|---|---|
| 2024-06-30 | $109.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-29 | $291.96K 10-Q · filed 2024-08-29 |
| 2024-03-31 | $182.93K 10-Q · filed 2024-05-20 | |
| 2023-06-30 | $214.00K 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |